Search Results - "RADNIK, B. J"

Adverse effects of recombinant human insulin-like growth factor I in obese insulin-resistant type II diabetic patients by Jabri, N., Schalch, D. S., Schwartz, S. L., Fischer, J. S., Kipnes, M. S., Radnik, B. J., Turman, N. J., Marcsisin, V. S., Guler, H. P.

“…Adverse effects of recombinant human insulin-like growth factor I in obese insulin-resistant type II diabetic patients. N Jabri , D S Schalch , S L Schwartz ,…”
Get full text

Adverse effects of recombinant human insulin-like growth factor I in obese insulin-resistant type II diabetic patients by JABRI, N, SCHALCH, D. S, SCHWARTZ, S. L, FISCHER, J. S, KIPNES, M. S, RADNIK, B. J, TURMAN, N. J, MARCSISIN, V. S, GULER, H.-P

“…Data from studies in diabetic rodents and evidence from clinical situations of severe resistance to insulin suggest that insulin-like growth factor I (IGF-I)…”
Get full text

Promotion and acceleration of diabetic ulcer healing by arginine-glycine-aspartic acid (RGD) peptide matrix by STEED, D. L, RICOTTA, J. J, PRENDERGAST, J. J, KAPLAN, R. J, WEBSTER, M. W, MCGILL, J. B, SCHWARTZ, S. L

“…OBJECTIVE To determine the effectiveness and safety of arginine-glycine-aspartic acid (RGD) peptide matrix in the treatment of diabetic foot ulcers. RESEARCH…”
Get full text